Browse drugs

…ssive metastases. Adoptive treatment with γδT cells or use of a PROS1 inhibitor may be a viable therapeutic option for metastasis in …

…ey produce IFN-γ, TNF-α, IL-17, and cytotoxic molecules such as granzyme B and perforin. In cancer, MAIT cells exhibit both anti- and pro-…

…ts with PD-L1/PD-L2 co-amplification.In the patients, receiving anti PD-1, patients with PD-L1/PD-L2 co-amplification had higher OS compa…

… dark matter elements shared with a dark matter cancer vaccine, DPV-001, administered as immunotherapy to patients with HNSCC and NSCLC…

…oneedle (MN) patch by integrating acid and ROS dual-activatable PROTAC nanoparticles and self-oxygenating BSA-MnO 2 nanoparticles into…

…ls driving effector functions that mediate anti-tumor activity. ANK-101 (tolododekin alfa) is an alum-anchored IL-12 drug conjugate des…

…d P, Skidmore ZL, Nussenbaum B, et al. Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated …

…-T cells, either alone or in combination with the ALK inhibitor lorlatinib. Tumor monitoring was performed weekly using IVIS imaging.Resul…

… signal 1 booster construct after 7 days of treatment -/+100 nM rimiducid in the presence of IL-2. (B) Expansion of T cells expressing th…

…g limitations into CNS tumors as they naturally migrate towards CCL2, which is overexpressed in medulloblastoma. Additionally, they …

…rter cell line and selected for GFP(+) cells in the presence of rimiducid. After three rounds of induction with rimiducid, >100 variants …

…ription factor Inhibitor of DNA binding 3 (Id3) in CAR T cells (Id3-CAR) augments durable solid tumor control in vivo, which lasted up …